Recent Finacing
Recent Raise
Integrated Biotherapeutics develops a multivalent Staphylococcus aureus toxoid vaccine (IBT‑V02), plus freeze‑dried formulations, and partners with global research organizations and U.S. government agencies for strain testing and trials.
